BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12436019)

  • 1. Current progress in schizophrenia research: application of emerging "gene chip" technologies in search of genes.
    Thaker GK
    J Nerv Ment Dis; 2002 Nov; 190(11):781. PubMed ID: 12436019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene-expression profiling in schizophrenia: an overview].
    Verveer J; Huizer K; Fekkes D; van Beveren NJ
    Tijdschr Psychiatr; 2007; 49(1):7-16; discussion 17-9. PubMed ID: 17225200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel missense polymorphism in the regulator of G-protein signaling 10 gene: analysis of association with schizophrenia.
    Hishimoto A; Shirakawa O; Nishiguchi N; Aoyama S; Ono H; Hashimoto T; Maeda K
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):579-81. PubMed ID: 15482592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):31-6. PubMed ID: 12625025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia.
    Sivagnanasundaram S; Fletcher D; Hubank M; Illingworth E; Skuse D; Scambler P
    Brain Res; 2007 Mar; 1139():48-59. PubMed ID: 17292336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells.
    Altar CA; Hunt RA; Jurata LW; Webster MJ; Derby E; Gallagher P; Lemire A; Brockman J; Laeng P
    Biol Psychiatry; 2008 Dec; 64(12):1077-87. PubMed ID: 18973876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping by genetic association implicates the chromosome 1q23.3 gene UHMK1, encoding a serine/threonine protein kinase, as a novel schizophrenia susceptibility gene.
    Puri V; McQuillin A; Choudhury K; Datta S; Pimm J; Thirumalai S; Krasucki R; Lawrence J; Quested D; Bass N; Moorey H; Morgan J; Punukollu B; Kandasami G; Curtis D; Gurling H
    Biol Psychiatry; 2007 Apr; 61(7):873-9. PubMed ID: 16978587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.
    Schmitt A; Leonardi-Essmann F; Durrenberger PF; Parlapani E; Schneider-Axmann T; Spanagel R; Arzberger T; Kretzschmar H; Herrera-Marschitz M; Gruber O; Reynolds R; Falkai P; Gebicke-Haerter PJ
    World J Biol Psychiatry; 2011 Apr; 12(3):201-15. PubMed ID: 21091092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the neurobiology of schizophrenia.
    Miyamoto S; LaMantia AS; Duncan GE; Sullivan P; Gilmore JH; Lieberman JA
    Mol Interv; 2003 Feb; 3(1):27-39. PubMed ID: 14993436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in the genetics of schizophrenia and the practical implications of the results].
    Réthelyi J; Polgár P; Czobor P; Bitter I
    Psychiatr Hung; 2008; 23(3):152-65. PubMed ID: 18956622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression.
    Sugai T; Kawamura M; Iritani S; Araki K; Makifuchi T; Imai C; Nakamura R; Kakita A; Takahashi H; Nawa H
    Ann N Y Acad Sci; 2004 Oct; 1025():84-91. PubMed ID: 15542704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene brain structure relationships: arbitrary assumptions of heterogeneity generate unfalsifiable claims.
    Crow TJ; DeLisi L
    Arch Gen Psychiatry; 2007 Sep; 64(9):1097-8; author reply 1098-9. PubMed ID: 17768277
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
    Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
    J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia.
    Cui DH; Jiang KD; Jiang SD; Xu YF; Yao H
    Mol Psychiatry; 2005 Jul; 10(7):669-77. PubMed ID: 15768050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
    Katsel PL; Davis KL; Haroutunian V
    Int Rev Neurobiol; 2005; 63():41-82. PubMed ID: 15797465
    [No Abstract]   [Full Text] [Related]  

  • 16. Schizophrenia susceptibility genes: emergence of positional candidates and future directions.
    Gogos JA; Gerber DJ
    Trends Pharmacol Sci; 2006 Apr; 27(4):226-33. PubMed ID: 16530856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on key previously proposed candidate genes for schizophrenia.
    Schwab SG; Wildenauer DB
    Curr Opin Psychiatry; 2009 Mar; 22(2):147-53. PubMed ID: 19553868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
    Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
    Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.
    Seeman P; Ko F; Jack E; Greenstein R; Dean B
    Synapse; 2007 May; 61(5):303-9. PubMed ID: 17318883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristic gene expression in autopsy brain tissues of patients with schizophrenia--analysis by DNA chip].
    Ikeda K
    Seishin Shinkeigaku Zasshi; 2002; 104(6):493-500. PubMed ID: 12373804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.